Douglas Lane & Associates, LLC Becton Dickinson & CO Transaction History

Douglas Lane & Associates, LLC

  • $6.9 Billion
  • Q3 2025

A detailed history of Douglas Lane & Associates, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 1,345 shares of BDX stock, worth $256,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,345
Previous 1,563 13.95%
Holding current value
$256,868
Previous $269,000 6.69%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025
SELL
$172.41 - $199.66 $37,585 - $43,525
-218 Reduced 13.95%
1,345 $251,000
Q2 2025

Jul 07, 2025
BUY
$165.15 - $226.42 $13,377 - $18,340
81 Added 5.47%
1,563 $269,000
Q1 2025

Apr 09, 2025
SELL
$222.79 - $249.08 $11,585 - $12,952
-52 Reduced 3.39%
1,482 $339,000
Q4 2024

Jan 08, 2025
SELL
$220.02 - $243.75 $19,361 - $21,450
-88 Reduced 5.43%
1,534 $348,000
Q3 2024

Oct 10, 2024
SELL
$221.47 - $242.41 $27,240 - $29,816
-123 Reduced 7.05%
1,622 $391,000
Q2 2024

Jul 08, 2024
BUY
$225.07 - $246.17 $40,962 - $44,802
182 Added 11.64%
1,745 $407,000
Q1 2024

Apr 11, 2024
BUY
$233.45 - $247.73 $4,202 - $4,459
18 Added 1.17%
1,563 $386,000
Q4 2023

Jan 17, 2024
SELL
$232.24 - $267.23 $29,030 - $33,403
-125 Reduced 7.49%
1,545 $376,000
Q3 2023

Oct 16, 2023
SELL
$254.9 - $283.59 $1,529 - $1,701
-6 Reduced 0.36%
1,670 $431,000
Q2 2023

Jul 19, 2023
SELL
$238.39 - $265.32 $7,151 - $7,959
-30 Reduced 1.76%
1,676 $442,000
Q1 2023

Apr 17, 2023
SELL
$229.71 - $259.35 $5,742 - $6,483
-25 Reduced 1.44%
1,706 $422,000
Q4 2022

Jan 17, 2023
SELL
$218.29 - $256.91 $21,829 - $25,691
-100 Reduced 5.46%
1,731 $440,000
Q3 2022

Oct 14, 2022
SELL
$51.03 - $264.23 $510 - $2,642
-10 Reduced 0.54%
1,831 $408,000
Q2 2022

Jul 18, 2022
SELL
$234.74 - $275.42 $17,840 - $20,931
-76 Reduced 3.96%
1,841 $454,000
Q1 2022

Apr 25, 2022
SELL
$243.64 - $270.48 $17,542 - $19,474
-72 Reduced 3.62%
1,917 $510,000
Q4 2021

Jan 25, 2022
SELL
$230.08 - $250.94 $44,405 - $48,431
-193 Reduced 8.85%
1,989 $500,000
Q2 2021

Jul 19, 2021
SELL
$232.65 - $254.58 $25,591 - $28,003
-110 Reduced 4.8%
2,182 $531,000
Q1 2021

Apr 19, 2021
SELL
$232.09 - $256.88 $45,257 - $50,091
-195 Reduced 7.84%
2,292 $557,000
Q4 2020

Jan 14, 2021
BUY
$221.92 - $245.94 $5,548 - $6,148
25 Added 1.02%
2,487 $622,000
Q3 2020

Oct 19, 2020
BUY
$215.77 - $276.76 $4,099 - $5,258
19 Added 0.78%
2,462 $573,000
Q2 2020

Jul 28, 2020
BUY
$219.9 - $263.41 $10,335 - $12,380
47 Added 1.96%
2,443 $585,000
Q1 2020

Apr 20, 2020
SELL
$195.69 - $279.01 $63,599 - $90,678
-325 Reduced 11.94%
2,396 $551,000
Q4 2019

Jan 27, 2020
SELL
$236.45 - $266.82 $24,354 - $27,482
-103 Reduced 3.65%
2,721 $740,000
Q3 2019

Oct 16, 2019
BUY
$230.58 - $256.08 $81,625 - $90,652
354 Added 14.33%
2,824 $714,000
Q2 2019

Jul 08, 2019
SELL
$217.4 - $246.08 $3,695 - $4,183
-17 Reduced 0.68%
2,470 $622,000
Q1 2019

Apr 23, 2019
SELL
$206.05 - $248.17 $6,593 - $7,941
-32 Reduced 1.27%
2,487 $621,000
Q4 2018

Jan 17, 2019
SELL
$204.73 - $257.93 $409 - $515
-2 Reduced 0.08%
2,519 $568,000
Q3 2018

Oct 09, 2018
BUY
$233.07 - $256.0 $89,965 - $98,816
386 Added 18.08%
2,521 $658,000
Q2 2018

Jul 23, 2018
SELL
$208.1 - $233.85 $43,909 - $49,342
-211 Reduced 8.99%
2,135 $511,000
Q1 2018

Apr 23, 2018
BUY
$205.46 - $240.27 $10,273 - $12,013
50 Added 2.18%
2,346 $508,000
Q4 2017

Jan 24, 2018
SELL
$189.0 - $222.64 $4,725 - $5,566
-25 Reduced 1.08%
2,296 $491,000
Q3 2017

Oct 19, 2017
BUY
$186.89 - $198.9 $433,771 - $461,646
2,321
2,321 $455,000

Others Institutions Holding BDX

# of Institutions
1,718
Shares Held
257M
Call Options Held
1.01M
Put Options Held
544K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email